Design, Synthesis, Biological Evaluation and Docking, ADME Studies of Novel Phenylsulfonyl Piperazine Analogues as α-Amylase Inhibitors
Abstract
Diabetes mellitus (DM) stands as one of the most widespread diseases encountered today. It is primarily characterized by diminished insulin levels and heightened blood glucose concentrations. Inhibition of the α-amylase enzyme plays a pivotal role in the management of diabetes mellitus. Piperazine and sulfonamide groups are recognized for their extensive range of biological effects. The current study involved synthesizing five phenylsulfonyl piperazine derivatives. An evaluation of their α-amylase inhibitory capacities was conducted. Phenylsulfonyl piperazine derivatives (compounds 1-5) exhibited notable α-amylase enzymatic inhibition, with compound 4 showing the most substantial potential for inhibition. The inhibitory percentage of compound 4 (80.61±0.62) surpassed that of the standard drug acarbose (78.81±0.02). The molecular docking studies identified compound 4 as possessing the most substantial inhibitory effect on the α-amylase enzyme, with notable binding energy -8.2 kcal/mol. This compound exhibited specific interactions, including π-π stacking and π-anion interactions with key enzyme residues, solidifying its role as a potent inhibitor
Keywords
Diabetes mellitus, α-Amylase, Piperazine, Sulfonamide
Supporting Institution
University of Health Sciences, unit of scientific research project (BAP)
Project Number
2020/040
References
- [1] Mittal K.R., Mishra R., Sharma V., Mishra I., 1,3,4-Thiadiazole: A Versatile Scaffold for Drug Discovery [Internet]. Vol. 21, Letters in Organic Chemistry, 21 (2024) 400–413.
- [2] Mishra R., Sharma P.K., Verma P.K., Tomer I., Mathur G., Dhakad P.K., Biological Potential of Thiazole Derivatives of Synthetic Origin, J. Heterocycl Chem., 54(4) (2017) 2103-2116.
- [3] Mishra I., Chandra P., Sachan N., Thiazole Derivatives as RORγt Inhibitors: Synthesis, Biological Evaluation, and Docking Analysis, Letters in Drug Design & Discovery, 21 (2024) 905–17.
- [4] Mishra R., Kumar N., Mishra I., Sachan N., A Review on Anticancer Activities of Thiophene and Its Analogs, Mini-Reviews in Medicinal Chemistry. 20 (2020) 1944–1965.
- [5] Mittal K.R., Purohit P., Quinoline-3-carboxylate Derivatives: A New Hope as an Antiproliferative Agent, Anti-Cancer Agents in Medicinal Chemistry. 20 (2020) 1981–1991.
- [6] Vitaku E, Smith DT, Njardarson JT. Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals. J Med Chem [Internet]. 2014 Dec 26;57(24):10257–74.
- [7] Mukherjee D., Mukhopadhyay A., Bhat K.S., Shridhara A.M., Rao K.S., Synthesis, characterization and anticonvulsant activity of substituted 4- chloro-2-(4-piperazin-1-YL) quinazolines, Int. J. Pharm. Sci., 6(5) (2014) 567–571.
- [8] Kálai T., Khan M., Balog M., Kutala V.K., Kuppusamy P., Hideg K., Structure-activity studies on the protection of Trimetazidine derivatives modified with nitroxides and their precursors from myocardial ischemia-reperfusion injury, Bioorg Med Chem., 14(16) (2006) 5510–5516.
- [9] Buran K., Reis R., Sipahi H., Önen Bayram F.E., Piperazine and piperidine-substituted 7-hydroxy coumarins for the development of anti-inflammatory agents, Arch. Pharm. (Weinheim) 354(7) (2021) 2000354.
- [10] Buran K., Bua S., Poli G., Bayram F.E.Ö., Tuccinardi T., Supuran C.T., Novel 8-substituted coumarins that selectively inhibit human carbonic anhydrase IX and XII, Int. J. Mol. Sci., 20(5) (2019).